Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amdocs (DOX) Other Operating Expenses: 2012-2025

Historic Other Operating Expenses for Amdocs (DOX) over the last 12 years, with Mar 2025 value amounting to $747.2 million.

  • Amdocs' Other Operating Expenses rose 435.32% to $747.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $5.2 billion, marking a year-over-year increase of 64.23%. This contributed to the annual value of $2.9 billion for FY2025, which is 13.22% down from last year.
  • Per Amdocs' latest filing, its Other Operating Expenses stood at $747.2 million for Q1 2025, which was up 7.05% from $698.0 million recorded in Q4 2024.
  • In the past 5 years, Amdocs' Other Operating Expenses ranged from a high of $4.0 billion in Q3 2024 and a low of -$228.2 million during Q2 2024.
  • Its 3-year average for Other Operating Expenses is $907.9 million, with a median of -$173.2 million in 2023.
  • As far as peak fluctuations go, Amdocs' Other Operating Expenses tumbled by 41.31% in 2021, and later spiked by 483.62% in 2024.
  • Amdocs' Other Operating Expenses (Quarterly) stood at -$211.7 million in 2021, then increased by 18.59% to -$172.3 million in 2022, then declined by 5.59% to -$182.0 million in 2023, then surged by 483.62% to $698.0 million in 2024, then spiked by 435.32% to $747.2 million in 2025.
  • Its Other Operating Expenses stands at $747.2 million for Q1 2025, versus $698.0 million for Q4 2024 and $4.0 billion for Q3 2024.